These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 32279124)

  • 1. Postoperative C-reactive protein/albumin ratio is a biomarker of risk of recurrence and need for adjuvant chemotherapy for stage III colorectal cancer.
    Matsuoka H; Ando K; Hu Q; Zaitsu Y; Tsuda Y; Hisamatsu Y; Nakashima Y; Kimura Y; Oki E; Mori M
    Int J Clin Oncol; 2020 Jul; 25(7):1318-1326. PubMed ID: 32279124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer.
    Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Shibuya N; Kubota K
    Ann Surg Oncol; 2016 Mar; 23(3):900-7. PubMed ID: 26530445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patients.
    Yamauchi Y; Safi S; Muley T; Warth A; Herth FJF; Dienemann H; Hoffmann H; Eichhorn ME
    Lung Cancer; 2017 Dec; 114():62-67. PubMed ID: 29173768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of the C-Reactive Protein/Albumin Ratio and Systemic Immune-Inflammation Index for Patients With Colorectal Liver Metastasis Undergoing Curative Resection.
    Deng Y; Zhao Y; Qin J; Huang X; Wu R; Zhou C; Pan Z
    Pathol Oncol Res; 2021; 27():633480. PubMed ID: 34257601
    [No Abstract]   [Full Text] [Related]  

  • 5. Significance of the 7th postoperative day neutrophil-to-lymphocyte ratio in colorectal cancer.
    Hayama T; Hashiguchi Y; Okada Y; Ono K; Nemoto K; Shimada R; Ozawa T; Toyoda T; Tsuchiya T; Iinuma H; Nozawa K; Matsuda K
    Int J Colorectal Dis; 2020 Jan; 35(1):119-124. PubMed ID: 31797097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer.
    Toyokawa T; Muguruma K; Yoshii M; Tamura T; Sakurai K; Kubo N; Tanaka H; Lee S; Yashiro M; Ohira M
    BMC Cancer; 2020 Jun; 20(1):517. PubMed ID: 32493247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment C-reactive protein/albumin ratio is associated with poor survival in patients with stage IB-IIA cervical cancer.
    Zhang W; Liu K; Ye B; Liang W; Ren Y
    Cancer Med; 2018 Jan; 7(1):105-113. PubMed ID: 29193777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative, but not preoperative, inflammation-based prognostic markers are prognostic factors in stage III colorectal cancer patients.
    Yasui K; Shida D; Nakamura Y; Ahiko Y; Tsukamoto S; Kanemitsu Y
    Br J Cancer; 2021 Mar; 124(5):933-941. PubMed ID: 33257844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Adjuvant Chemotherapy According to the Classification of Recurrence Risk Based on Systemic Inflammatory Markers in Patients With Liver Metastases of Colorectal Cancer.
    Shibutani M; Nagahara H; Fukuoka T; Iseki Y; Hirakawa K; Ohira M
    Anticancer Res; 2019 Sep; 39(9):5039-5045. PubMed ID: 31519612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic immune-inflammation index for predicting prognosis of colorectal cancer.
    Chen JH; Zhai ET; Yuan YJ; Wu KM; Xu JB; Peng JJ; Chen CQ; He YL; Cai SR
    World J Gastroenterol; 2017 Sep; 23(34):6261-6272. PubMed ID: 28974892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [C-reactive protein/albumin ratio as a novel inflammation-based prognostic index for predicting outcomes of patients with colorectal cancer].
    Chen YY; Zhang JH; Zhang W; Yang ZK; Luo RC; Kang SJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 May; 37(5):622-627. PubMed ID: 28539284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis.
    Wu Y; Li C; Zhao J; Yang L; Liu F; Zheng H; Wang Z; Xu Y
    World J Surg Oncol; 2016 Nov; 14(1):289. PubMed ID: 27852294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive Values of Postoperative and Dynamic Changes of Inflammation Indexes in Survival of Patients with Resected Colorectal Cancer.
    Zhou ZQ; Pang S; Yu XC; Xue Q; Jiang HY; Liang XJ; Liu L
    Curr Med Sci; 2018 Oct; 38(5):798-808. PubMed ID: 30341514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of changes in serum-based inflammatory indicators to monitor response to nivolumab monotherapy in advanced gastric cancer: a multicenter retrospective study.
    Inukai M; Nishi T; Matsuoka H; Matsuo K; Suzuki K; Serizawa A; Akimoto S; Nakauchi M; Tanaka T; Kikuchi K; Shibasaki S; Uyama I; Suda K
    BMC Cancer; 2024 Sep; 24(1):1121. PubMed ID: 39251991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C-reactive protein to albumin ratio predicts postoperative complications in oldest-old patients with colorectal cancer.
    Hashimoto S; Tominaga T; Nonaka T; Hamada K; Araki M; Takeshita H; Fukuoka H; Wada H; To K; Komatsu H; Tanaka K; Sawai T; Nagayasu T
    Int J Colorectal Dis; 2020 Mar; 35(3):423-431. PubMed ID: 31897648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of postoperative inflammation on recurrence in patients with colorectal cancer.
    Matsubara D; Arita T; Nakanishi M; Kuriu Y; Murayama Y; Kudou M; Konishi H; Komatsu S; Shiozaki A; Otsuji E
    Int J Clin Oncol; 2020 Apr; 25(4):602-613. PubMed ID: 31758273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The C-Reactive Protein to Albumin Ratio as a Predictor of Severe Side Effects of Adjuvant Chemotherapy in Stage III Colorectal Cancer Patients.
    Tominaga T; Nonaka T; Sumida Y; Hidaka S; Sawai T; Nagayasu T
    PLoS One; 2016; 11(12):e0167967. PubMed ID: 27930703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer.
    Peng J; Zhang R; Zhao Y; Wu X; Chen G; Wan D; Lu Z; Pan Z
    Chin J Cancer; 2017 Dec; 36(1):96. PubMed ID: 29268783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative Neutrophil-to-Lymphocyte Ratio is a Better Prognostic Serum Biomarker than Platelet-to-Lymphocyte Ratio in Patients Undergoing Resection for Nonmetastatic Colorectal Cancer.
    Choi WJ; Cleghorn MC; Jiang H; Jackson TD; Okrainec A; Quereshy FA
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S603-13. PubMed ID: 25900206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-Reactive Protein/Albumin Ratio Is an Independent Risk Factor for Recurrence and Survival Following Curative Resection of Stage I-III Colorectal Cancer in Older Patients.
    Bekki T; Shimomura M; Hattori M; Sato S; Watanabe A; Ishikawa S; Imaoka K; Ono K; Matsubara K; Mochizuki T; Akabane S; Yano T; Ohdan H
    Ann Surg Oncol; 2024 Jul; 31(7):4812-4821. PubMed ID: 38280961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.